BERLIN (MedPage Today) -- For patients with impaired glucose tolerance or early diabetes, use of insulin glargine (Lantus) was the best predictor of maintaining a lower hemoglobin A1c (HbA1c) level over 5 years, according to a subanalysis of the ORIGIN trial. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment